GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-F) » Definitions » Gross Margin %

Mega Lifesciences PCL (BKK:MEGA-F) Gross Margin % : 46.84% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Mega Lifesciences PCL's Gross Profit for the three months ended in Mar. 2024 was ฿1,748.55 Mil. Mega Lifesciences PCL's Revenue for the three months ended in Mar. 2024 was ฿3,732.66 Mil. Therefore, Mega Lifesciences PCL's Gross Margin % for the quarter that ended in Mar. 2024 was 46.84%.


The historical rank and industry rank for Mega Lifesciences PCL's Gross Margin % or its related term are showing as below:

BKK:MEGA-F' s Gross Margin % Range Over the Past 10 Years
Min: 39.61   Med: 42.37   Max: 45.25
Current: 46.02


During the past 13 years, the highest Gross Margin % of Mega Lifesciences PCL was 45.25%. The lowest was 39.61%. And the median was 42.37%.

BKK:MEGA-F's Gross Margin % is ranked worse than
51.63% of 984 companies
in the Drug Manufacturers industry
Industry Median: 46.73 vs BKK:MEGA-F: 46.02

Mega Lifesciences PCL had a gross margin of 46.84% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Mega Lifesciences PCL was 1.60% per year.


Mega Lifesciences PCL Gross Margin % Historical Data

The historical data trend for Mega Lifesciences PCL's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Gross Margin % Chart

Mega Lifesciences PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.14 39.61 41.81 44.88 45.25

Mega Lifesciences PCL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.62 45.71 45.73 45.83 46.84

Competitive Comparison of Mega Lifesciences PCL's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Gross Margin % falls into.



Mega Lifesciences PCL Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Mega Lifesciences PCL's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=7095.4 / 15681.172
=(Revenue - Cost of Goods Sold) / Revenue
=(15681.172 - 8585.796) / 15681.172
=45.25 %

Mega Lifesciences PCL's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=1748.6 / 3732.661
=(Revenue - Cost of Goods Sold) / Revenue
=(3732.661 - 1984.108) / 3732.661
=46.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Mega Lifesciences PCL  (BKK:MEGA-F) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Mega Lifesciences PCL had a gross margin of 46.84% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Mega Lifesciences PCL Gross Margin % Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL (BKK:MEGA-F) Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea,Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods as well as the provides distribution services relating to such products. The company's products portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purpose and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL (BKK:MEGA-F) Headlines

No Headlines